Concepts (143)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Colorectal Neoplasms, Hereditary Nonpolyposis | 7 | 2023 | 380 | 3.430 |
Why?
|
Neoplastic Syndromes, Hereditary | 2 | 2021 | 245 | 0.770 |
Why?
|
Colorectal Neoplasms | 4 | 2023 | 6925 | 0.770 |
Why?
|
DNA Mismatch Repair | 2 | 2021 | 428 | 0.720 |
Why?
|
Intestinal Polyposis | 1 | 2020 | 42 | 0.680 |
Why?
|
Stomach Diseases | 1 | 2020 | 134 | 0.620 |
Why?
|
Genetic Testing | 3 | 2023 | 3533 | 0.600 |
Why?
|
Watchful Waiting | 1 | 2019 | 491 | 0.480 |
Why?
|
Pancreatic Neoplasms | 5 | 2024 | 5367 | 0.480 |
Why?
|
Colectomy | 1 | 2019 | 686 | 0.450 |
Why?
|
Germ-Line Mutation | 1 | 2021 | 1852 | 0.410 |
Why?
|
Rectal Neoplasms | 1 | 2021 | 1156 | 0.400 |
Why?
|
Colonic Neoplasms | 1 | 2021 | 2533 | 0.330 |
Why?
|
Adenoma | 1 | 2019 | 2159 | 0.320 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2011 | 625 | 0.270 |
Why?
|
Microsatellite Instability | 2 | 2019 | 716 | 0.250 |
Why?
|
Genetic Predisposition to Disease | 5 | 2022 | 17878 | 0.190 |
Why?
|
Antineoplastic Agents | 3 | 2023 | 13635 | 0.190 |
Why?
|
Heredity | 1 | 2021 | 148 | 0.180 |
Why?
|
Anus Neoplasms | 1 | 2024 | 329 | 0.170 |
Why?
|
Molecular Diagnostic Techniques | 2 | 2023 | 610 | 0.170 |
Why?
|
Interleukin-1beta | 1 | 2024 | 998 | 0.160 |
Why?
|
Neutropenia | 1 | 2023 | 885 | 0.150 |
Why?
|
Early Detection of Cancer | 2 | 2023 | 3196 | 0.150 |
Why?
|
Neoplasms | 3 | 2024 | 22131 | 0.140 |
Why?
|
Gastric Mucosa | 1 | 2020 | 603 | 0.140 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2024 | 1727 | 0.130 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2023 | 955 | 0.120 |
Why?
|
Germ Cells | 1 | 2019 | 634 | 0.120 |
Why?
|
Smoking | 1 | 2011 | 9050 | 0.120 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2024 | 11736 | 0.120 |
Why?
|
Humans | 24 | 2024 | 760617 | 0.120 |
Why?
|
Pancreas | 1 | 2021 | 1690 | 0.120 |
Why?
|
Coronary Circulation | 3 | 2009 | 1569 | 0.120 |
Why?
|
Body Composition | 1 | 2023 | 2426 | 0.110 |
Why?
|
Age Factors | 2 | 2021 | 18381 | 0.110 |
Why?
|
Pedigree | 1 | 2021 | 4539 | 0.110 |
Why?
|
Radiotherapy | 1 | 2020 | 1497 | 0.110 |
Why?
|
Phenotype | 3 | 2021 | 16571 | 0.110 |
Why?
|
Syndrome | 1 | 2019 | 3268 | 0.100 |
Why?
|
Weight Loss | 1 | 2024 | 2682 | 0.100 |
Why?
|
Papillomavirus Infections | 1 | 2024 | 1611 | 0.100 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2019 | 3514 | 0.090 |
Why?
|
Deoxycytidine | 2 | 2024 | 878 | 0.080 |
Why?
|
Risk Factors | 3 | 2021 | 74115 | 0.080 |
Why?
|
No-Reflow Phenomenon | 1 | 2008 | 16 | 0.080 |
Why?
|
Intestinal Mucosa | 1 | 2020 | 3031 | 0.080 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2024 | 4020 | 0.080 |
Why?
|
Chimerism | 1 | 2008 | 155 | 0.070 |
Why?
|
Myocardial Reperfusion | 1 | 2008 | 338 | 0.070 |
Why?
|
Female | 11 | 2024 | 392148 | 0.070 |
Why?
|
Sex Factors | 1 | 2021 | 10548 | 0.070 |
Why?
|
Survival Rate | 1 | 2021 | 12719 | 0.070 |
Why?
|
Paclitaxel | 2 | 2024 | 1730 | 0.070 |
Why?
|
Adenocarcinoma | 1 | 2023 | 6340 | 0.070 |
Why?
|
Angioplasty, Balloon, Coronary | 2 | 2009 | 1725 | 0.060 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2009 | 851 | 0.060 |
Why?
|
Male | 8 | 2024 | 360358 | 0.060 |
Why?
|
Microcirculation | 1 | 2008 | 1272 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2019 | 10199 | 0.050 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2009 | 1493 | 0.050 |
Why?
|
Prevalence | 1 | 2019 | 15689 | 0.050 |
Why?
|
Cachexia | 1 | 2023 | 202 | 0.050 |
Why?
|
Prognosis | 2 | 2021 | 29600 | 0.050 |
Why?
|
Cohort Studies | 2 | 2023 | 41457 | 0.050 |
Why?
|
Intention | 1 | 2024 | 346 | 0.050 |
Why?
|
Tumor Microenvironment | 2 | 2024 | 3868 | 0.050 |
Why?
|
Young Adult | 3 | 2020 | 59179 | 0.040 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2023 | 629 | 0.040 |
Why?
|
Muscular Atrophy | 1 | 2023 | 334 | 0.040 |
Why?
|
Thrombolytic Therapy | 1 | 2009 | 2055 | 0.040 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2009 | 1310 | 0.040 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 26049 | 0.040 |
Why?
|
Coronary Angiography | 2 | 2009 | 4470 | 0.040 |
Why?
|
Risk Assessment | 1 | 2021 | 23972 | 0.040 |
Why?
|
Internet | 1 | 2011 | 3090 | 0.040 |
Why?
|
Adolescent | 3 | 2020 | 88234 | 0.040 |
Why?
|
Middle Aged | 6 | 2024 | 220584 | 0.040 |
Why?
|
Acute Coronary Syndrome | 2 | 2008 | 2190 | 0.040 |
Why?
|
Brain Neoplasms | 1 | 2019 | 9026 | 0.040 |
Why?
|
Myocardium | 1 | 2009 | 4724 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2023 | 1835 | 0.030 |
Why?
|
Stress, Psychological | 1 | 2011 | 4488 | 0.030 |
Why?
|
Electrocardiography | 1 | 2009 | 6346 | 0.030 |
Why?
|
Treatment Outcome | 3 | 2019 | 64568 | 0.030 |
Why?
|
Adult | 4 | 2021 | 220969 | 0.030 |
Why?
|
Mutation | 1 | 2019 | 30016 | 0.030 |
Why?
|
Neoplasm Metastasis | 1 | 2024 | 4910 | 0.030 |
Why?
|
Severity of Illness Index | 1 | 2011 | 15828 | 0.030 |
Why?
|
Recombinant Proteins | 1 | 2023 | 6520 | 0.030 |
Why?
|
United States | 1 | 2021 | 72272 | 0.030 |
Why?
|
Body Weight | 1 | 2024 | 4614 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2009 | 8998 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 2 | 2009 | 36402 | 0.020 |
Why?
|
Prospective Studies | 3 | 2024 | 54360 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2023 | 3309 | 0.020 |
Why?
|
Medical Oncology | 1 | 2023 | 2317 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2024 | 4571 | 0.020 |
Why?
|
Health Personnel | 1 | 2024 | 3333 | 0.020 |
Why?
|
DNA | 1 | 2024 | 7196 | 0.020 |
Why?
|
Retrospective Studies | 2 | 2024 | 80566 | 0.020 |
Why?
|
Fetomaternal Transfusion | 1 | 2008 | 10 | 0.020 |
Why?
|
Cardiac Volume | 1 | 2009 | 196 | 0.020 |
Why?
|
Coronary Artery Disease | 1 | 2008 | 6403 | 0.020 |
Why?
|
Infusions, Intra-Arterial | 1 | 2008 | 221 | 0.020 |
Why?
|
Myocardial Infarction | 1 | 2009 | 11459 | 0.020 |
Why?
|
Endocardium | 1 | 2009 | 246 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2023 | 4947 | 0.020 |
Why?
|
Blood Preservation | 1 | 2008 | 169 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2023 | 5672 | 0.020 |
Why?
|
Ventricular Outflow Obstruction | 1 | 2009 | 261 | 0.020 |
Why?
|
Genomics | 1 | 2023 | 5822 | 0.020 |
Why?
|
Gadolinium DTPA | 1 | 2009 | 823 | 0.020 |
Why?
|
Myocardial Reperfusion Injury | 1 | 2009 | 481 | 0.020 |
Why?
|
Aged | 4 | 2024 | 169042 | 0.020 |
Why?
|
Radionuclide Imaging | 1 | 2009 | 1972 | 0.020 |
Why?
|
Pericardium | 1 | 2009 | 664 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2023 | 22115 | 0.010 |
Why?
|
Gadolinium | 1 | 2009 | 959 | 0.010 |
Why?
|
Microvessels | 1 | 2008 | 577 | 0.010 |
Why?
|
Clinical Trials as Topic | 2 | 2008 | 7995 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2024 | 39063 | 0.010 |
Why?
|
Fibrosis | 1 | 2009 | 2045 | 0.010 |
Why?
|
History, 21st Century | 1 | 2008 | 1565 | 0.010 |
Why?
|
Blood Transfusion | 1 | 2008 | 1299 | 0.010 |
Why?
|
Leukocytes | 1 | 2008 | 2023 | 0.010 |
Why?
|
History, 20th Century | 1 | 2008 | 2764 | 0.010 |
Why?
|
Anemia | 1 | 2008 | 1504 | 0.010 |
Why?
|
Fibrinolytic Agents | 1 | 2008 | 2073 | 0.010 |
Why?
|
Cell Survival | 1 | 2008 | 5780 | 0.010 |
Why?
|
Heart Ventricles | 1 | 2009 | 3796 | 0.010 |
Why?
|
Echocardiography | 1 | 2009 | 4987 | 0.010 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2008 | 2745 | 0.010 |
Why?
|
Hemorrhage | 1 | 2008 | 3418 | 0.010 |
Why?
|
Mice | 1 | 2023 | 81368 | 0.010 |
Why?
|
Contrast Media | 1 | 2009 | 5305 | 0.010 |
Why?
|
Cytokines | 1 | 2008 | 7373 | 0.010 |
Why?
|
Animals | 1 | 2023 | 168201 | 0.010 |
Why?
|
Incidence | 1 | 2008 | 21337 | 0.010 |
Why?
|
Time Factors | 1 | 2009 | 39913 | 0.000 |
Why?
|
Pregnancy | 1 | 2008 | 29868 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2009 | 58894 | 0.000 |
Why?
|
Child | 1 | 2009 | 80079 | 0.000 |
Why?
|
Concepts
(143)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(64)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_